J&J Board Changes and Executive Compensation Details

Ticker: JNJ · Form: 8-K · Filed: 2025-09-09T00:00:00.000Z

Sentiment: neutral

Topics: board-changes, executive-compensation, governance

Related Tickers: JNJ

TL;DR

J&J shakes up board, updates exec pay - watch for governance shifts.

AI Summary

Johnson & Johnson announced on September 8, 2025, changes in its board of directors and executive compensation. Specifically, the company reported the departure of Director Ellen M. Lord and the election of Director G. Steven Williams. Additionally, the filing details compensatory arrangements for certain officers, though specific dollar amounts for these arrangements are not provided in this excerpt.

Why It Matters

Changes in board composition and executive compensation can signal shifts in company strategy or governance, potentially impacting investor confidence and future performance.

Risk Assessment

Risk Level: low — This filing primarily concerns routine board and executive compensation updates, with no immediate financial distress or significant operational changes indicated.

Key Players & Entities

FAQ

Who has departed from Johnson & Johnson's board of directors?

Ellen M. Lord has departed from the board of directors.

Who has been elected as a new director to Johnson & Johnson's board?

G. Steven Williams has been elected as a new director.

What is the filing date of this 8-K report?

The filing date is September 9, 2025.

What is the date as of which the changes reported in the 8-K occurred?

The date as of the change is September 8, 2025.

What are the main items covered in this 8-K filing?

This 8-K covers the departure of directors, election of directors, appointment of certain officers, and compensatory arrangements of certain officers.

From the Filing

0000200406-25-000190.txt : 20250909 0000200406-25-000190.hdr.sgml : 20250909 20250908195525 ACCESSION NUMBER: 0000200406-25-000190 CONFORMED SUBMISSION TYPE: 8-K PUBLIC DOCUMENT COUNT: 16 CONFORMED PERIOD OF REPORT: 20250908 ITEM INFORMATION: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers FILED AS OF DATE: 20250909 DATE AS OF CHANGE: 20250908 FILER: COMPANY DATA: COMPANY CONFORMED NAME: JOHNSON & JOHNSON CENTRAL INDEX KEY: 0000200406 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] ORGANIZATION NAME: 03 Life Sciences EIN: 221024240 STATE OF INCORPORATION: NJ FISCAL YEAR END: 1228 FILING VALUES: FORM TYPE: 8-K SEC ACT: 1934 Act SEC FILE NUMBER: 001-03215 FILM NUMBER: 251301386 BUSINESS ADDRESS: STREET 1: ONE JOHNSON & JOHNSON PLZ CITY: NEW BRUNSWICK STATE: NJ ZIP: 08933 BUSINESS PHONE: 732-524-2455 MAIL ADDRESS: STREET 1: ONE JOHNSON & JOHNSON PLZ CITY: NEW BRUNSWICK STATE: NJ ZIP: 08933 8-K 1 jnj-20250908.htm 8-K jnj-20250908 0000200406 false 0000200406 2025-09-08 2025-09-08 0000200406 us-gaap:CommonStockMember 2025-09-08 2025-09-08 0000200406 jnj:A1.150NotesDueNovember2028Member 2025-09-08 2025-09-08 0000200406 jnj:A2.700NotesDueFebruary2029Member 2025-09-08 2025-09-08 0000200406 jnj:A3.20NotesDueNovember2032Member 2025-09-08 2025-09-08 0000200406 jnj:A3.050NotesDueFebruary2033Member 2025-09-08 2025-09-08 0000200406 jnj:A1.650NotesDue2035Member 2025-09-08 2025-09-08 0000200406 jnj:A3.350NotesDueNovember2036Member 2025-09-08 2025-09-08 0000200406 jnj:A3.350NotesDueFebruary2037Member 2025-09-08 2025-09-08 0000200406 jnj:A3.550NotesDueNovember2044Member 2025-09-08 2025-09-08 0000200406 jnj:A3.600NotesDueFebruary2045Member 2025-09-08 2025-09-08 0000200406 jnj:A3.700NotesDueFebruary2055Member 2025-09-08 2025-09-08 UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 FORM  8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of The Securities Exchange Act of 1934 Date of report (Date of earliest event reported):  September 8, 2025 Johnson & Johnson (Exact name of registrant as specified in its charter) New Jersey 1-3215 22-1024240 (State or Other Jurisdiction of Incorporation) (Commission File Number) (IRS Employer Identification No.) One Johnson & Johnson Plaza , New Brunswick , New Jersey    08933   (Address of Principal Executive Offices)  (Zip Code)  Registrant's telephone number, including area code: 732 - 524-0400 Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions: ☐ Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425) ☐ Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12) ☐ Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))  ☐ Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c)) Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter). Emerging growth company ☐ If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐ SECURITIES REGISTERED PURSUANT TO SECTION 12(b) OF THE ACT Title of each class Trading Symbol(s) Name of each exchange on which registered Common Stock, Par Value $1.00 JNJ New York Stock Exchange 1.150% Notes Due November 2028 JNJ28 New York Stock Exchange 2.700% Notes due February 2029 JNJ29B New York Sto

View on Read The Filing